Menu
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.

Predictions

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€43.34
03.05.23
-
03.05.24
3.05%
13.05.23

buy
Medios AG

Start price
Target price
Perf. (%)
€25.20
03.05.22
€40.00
03.05.23
-28.02%
03.05.23

Could be very worthwhile Investment >20% year
Revenue growth > 30% per year expected
EBIT growth >5% per year expected
Lower EBIT Margin than peer group
buy
DIC Asset AG

Start price
Target price
Perf. (%)
€7.84
03.01.23
-
03.01.24
-15.56%
26.04.23

buy
Indus Holding AG

Start price
Target price
Perf. (%)
€22.25
03.01.23
-
03.01.24
19.55%
26.04.23

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€42.28
14.04.23
€50.00
14.05.23
-1.04%
15.04.23

Could be worthwhile Investment >10% per year
Undervalued
Hypoport SE

Start price
Target price
Perf. (%)
€139.30
24.01.23
-
24.01.24
-16.37%
22.03.23

Very low/no dividend yield expected
EBIT decline/stagnation expected
buy
DIC Asset AG

Start price
Target price
Perf. (%)
€14.15
08.03.22
-
08.03.23
-34.84%
09.03.23

buy
Deutsche Pfandbriefbank AG

Start price
Target price
Perf. (%)
€11.36
15.02.22
-
15.02.23
-19.06%
16.02.23

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€37.52
29.12.22
€50.00
29.12.23
-1.39%
07.01.23

Could be worthwhile Investment >10% per year
Undervalued
buy
DIC Asset AG

Start price
Target price
Perf. (%)
€10.58
02.08.22
€13.00
02.11.22
-31.00%
02.11.22

Patrizia Immobilien AG

Start price
Target price
Perf. (%)
€7.99
24.10.22
€7.00
24.10.23
-4.01%
29.10.22

Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
Business model of the past or high risk
buy
Hypoport SE

Start price
Target price
Perf. (%)
€78.45
23.09.22
-
23.10.22
13.58%
24.10.22

Risky Investment
Hypoport SE

Start price
Target price
Perf. (%)
€86.20
16.10.22
€90.00
16.10.23
-4.58%
17.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
buy
Hypoport SE

Start price
Target price
Perf. (%)
€88.85
11.10.22
€90.00
11.10.23
-2.98%
16.10.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
Higher EBIT margin than peer group
Standard Investments for future growth
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€84.50
14.09.21
-
14.09.22
-50.67%
15.09.22

buy
Patrizia Immobilien AG

Start price
Target price
Perf. (%)
€21.00
12.09.21
€23.50
12.09.22
-39.33%
13.09.22

Could be worthwhile Investment >10% per year
buy
Hypoport SE

Start price
Target price
Perf. (%)
€593.50
31.08.21
-
31.08.22
-67.67%
31.08.22

buy
Patrizia Immobilien AG

Start price
Target price
Perf. (%)
€20.90
23.12.21
-
23.12.22
-40.29%
25.08.22

buy
Grenke AG

Start price
Target price
Perf. (%)
€30.94
23.12.21
-
23.12.22
-21.14%
25.08.22

buy
Hypoport SE

Start price
Target price
Perf. (%)
€563.00
23.08.21
€570.00
23.08.22
-64.94%
24.08.22

Could be worthwhile Investment >10% per year
buy
Grand City Properties S.A.

Start price
Target price
Perf. (%)
€23.32
02.09.21
-
02.09.22
-47.00%
23.08.22

buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€55.50
02.08.22
€101.00
02.08.23
-0.36%
09.08.22

Could be worthwhile Investment >10% per year
Revenue growth >5% per year expected
EBIT growth >5% per year expected
Higher EBIT margin than peer group
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€69.00
10.07.21
-
10.07.22
-25.94%
11.07.22

Could be worthwhile Investment >10% per year
Capable Management
Differentiated customer and product portfolio
Growths faster than the competition
buy
Dermapharm Holding SE

Start price
Target price
Perf. (%)
€69.90
08.07.21
-
08.07.22
-27.04%
08.07.22

buy
Patrizia Immobilien AG

Start price
Target price
Perf. (%)
€21.25
22.11.21
€24.00
22.11.22
-41.84%
20.05.22

Normal challenges to pay loans and raise capital
Could be very worthwhile Investment >20% year
High dividend yield expected
Small Risks for its business